Vena and Acterys Recognized as Leaders in Info-Tech Research Group’s 2026 Enterprise Performance Management Data Quadrant Report September 22, 2026 Acterys ranks number one overall for the fourth consecutive year, with both Acterys and Vena earning leading marks across key Enterprise Performance Management (EPM) capabilities and product features.
Xpansiv and Verdane Announce Strategic Partnership and Capital Raise to Advance Global Acquisitions and Product Expansion September 22, 2026 Growth investment supports Xpansiv’s M&A strategy, international expansion, and product development
Bureau Veritas Confirms LEAP | 28 Ambition, Upgrades Total Revenue Growth to Double-Digit in 2027 – 20281 and Targets EUR1 Billion Revenue in AI-Driven Markets and Services by 2030 September 22, 2026 Bureau Veritas (BOURSE:BVI): CAPITAL MARKETS DAY 2026 Today, Bureau Veritas hosts its Capital Markets Day. The Company will present an update on the progress of its LEAP | 28 strategy, building on three years of successful execution. › 2024-2026 achievements: Proven track record: mid-to-high single-digit organic revenue growth (7-8%) delivered across 2023–2026e2, with 115 basis [...]
Up for the cup: Chelsea captain Erin Cuthbert on her coffee side hustle, Ruby Alba September 22, 2026 Being captain of the team that has won the Women’s Super League eight times in the last decade might be enough to keep most people busy, but not Chelsea’s Erin Cuthbert. Off the pitch, Cuthbert has her own coffee business, Ruby Alba, which she launched earlier this year in order to satisfy her entrepreneurial cravings [...]
Why the Revolut impersonation hack should be a wake-up call for the city September 22, 2026 The fact that a company as established as Revolut fell victim to such an attack underlines the threats facing financial services firms, says Graeme Stewart Who am I really talking too? That’s the uncomfortable question that is on everyone’s lips following reports that Revolut has been hit with a $3m ransom demand after a sophisticated impersonation scam. Indeed, the [...]
Truelink Capital, Goldenpeak, Allied Industrial Partners and Axiom Equity win Sagard Private Equity Emerging Manager of the Year Awards 2026 September 21, 2026 Sagard has named Truelink Capital II, Goldenpeak Fund I, Allied Industrial Partners and Axiom Equity as the winners of its 2026 Emerging Manager of the Year Awards.1 Established in 2024, the awards are being presented by Sagard for the first time following the completion of Sagard’s partnership with Unigestion. The awards recognize emerging managers, or [...]
Pierre Le Manh to Step Down as PMI President and CEO September 21, 2026 Project Management Institute (PMI), the leading authority in project management, today announced that Pierre Le Manh has decided to step down as President and Chief Executive Officer, effective September 30, 2026. Johannes Heinlein, Chief Growth Officer, has been appointed Interim President & Chief Executive Officer of PMI, also effective September 30, 2026. Pierre Le Manh [...]
Q4 Expands Connected IR Platform — Bringing More Market Intelligence and Earnings Workflows Together in One Place September 21, 2026 AI-powered Consensus & Public Guidance intelligence leads a series of enhancements designed to eliminate fragmented workflows, accelerate critical IR work, and give teams greater control
Fanplayr Rebrands to Verada, Reflecting the Growing Role of AI Across Its Platform September 21, 2026 Fanplayr, a leader in online business optimization and personalization, today announced its rebrand to Verada, marking a significant milestone in the company’s evolution into an AI-powered conversion optimization platform. Derived from ‘Verified Data,’ the Verada name reflects the platform it has become: one built around intelligent, verified data. It also reflects the company’s proprietary Verada [...]
Alkermes Announces Positive Phase 1b Results Demonstrating Clinical Proof-of-Concept for ALKS 7290 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) September 21, 2026 — ALKS 7290 is the First Orexin 2 Receptor Agonist to Demonstrate Clinically Meaningful Improvements in ADHD Symptoms in Adults — — ALKS 7290 Was Generally Well Tolerated at All Doses Tested in Healthy Volunteers and Adults With ADHD — — Phase 2 Study of ALKS 7290 in Adults With ADHD is Enrolling, Data Expected in 2027 —